BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei Z, Yuan S, Hao J, Fang X. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity. Eur J Pharm Biopharm 2013;83:266-74. [PMID: 23089310 DOI: 10.1016/j.ejpb.2012.09.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Albano JM, Ribeiro LNDM, Couto VM, Barbosa Messias M, Rodrigues da Silva GH, Breitkreitz MC, de Paula E, Pickholz M. Rational design of polymer-lipid nanoparticles for docetaxel delivery. Colloids and Surfaces B: Biointerfaces 2019;175:56-64. [DOI: 10.1016/j.colsurfb.2018.11.077] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
2 Nezhadi S, Saadat E, Handali S, Dorkoosh F. Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities. J Drug Target 2021;29:185-98. [PMID: 32772739 DOI: 10.1080/1061186X.2020.1808000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wan G, Liu Y, Shi S, Chen B, Wang Y, Wang H, Zhang L, Zhang N, Wang Y. Hematoporphyrin and doxorubicin co-loaded nanomicelles for the reversal of drug resistance in human breast cancer cells by combining sonodynamic therapy and chemotherapy. RSC Adv 2016;6:100361-72. [DOI: 10.1039/c6ra22724d] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 2022. [PMID: 35729778 DOI: 10.1021/acsnano.2c00128] [Reference Citation Analysis]
5 Al-ali AAA, Nielsen RB, Steffansen B, Holm R, Nielsen CU. Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption. International Journal of Pharmaceutics 2019;566:410-33. [DOI: 10.1016/j.ijpharm.2019.05.033] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
6 Gad SF, Park J, Park JE, Fetih GN, Tous SS, Lee W, Yeo Y. Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals. Mol Pharm 2018. [PMID: 29341617 DOI: 10.1021/acs.molpharmaceut.7b00783] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
7 Tang C, Meng K, Chen X, Yao H, Kong J, Li F, Yin H, Jin M, Liang H, Yuan Q. Preparation, Characterization, and In Vivo Evaluation of Amorphous Icaritin Nanoparticles Prepared by a Reactive Precipitation Technique. Molecules 2021;26:2913. [PMID: 34068926 DOI: 10.3390/molecules26102913] [Reference Citation Analysis]
8 Tasca E, Andreozzi P, Del Giudice A, Galantini L, Schillén K, Maria Giuliani A, Ramirez MLA, Moya SE, Giustini M. Poloxamer/sodium cholate co-formulation for micellar encapsulation of doxorubicin with high efficiency for intracellular delivery: An in-vitro bioavailability study. J Colloid Interface Sci 2020;579:551-61. [PMID: 32623121 DOI: 10.1016/j.jcis.2020.06.096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
9 Dehvari K, Lin K, Hammouda B. Small-angle neutron scattering studies of microenvironmental and structural changes of Pluronic micelles upon encapsulation of paclitaxel. Journal of the Taiwan Institute of Chemical Engineers 2017;71:405-13. [DOI: 10.1016/j.jtice.2016.11.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
10 Oh KS, Kim JY, Yoon BD, Lee M, Kim H, Kim M, Seo JH, Yuk SH. Sol–gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus. European Journal of Pharmaceutics and Biopharmaceutics 2014;88:664-9. [DOI: 10.1016/j.ejpb.2014.08.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bugno J, Poellmann MJ, Sokolowski K, Hsu H, Kim D, Hong S. Tumor penetration of Sub-10 nm nanoparticles: effect of dendrimer properties on their penetration in multicellular tumor spheroids. Nanomedicine: Nanotechnology, Biology and Medicine 2019;21:102059. [DOI: 10.1016/j.nano.2019.102059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jiang T, Zhang C, Sun W, Cao X, Choi G, Choy J, Shi X, Guo R. Doxorubicin Encapsulated in TPGS‐Modified 2D‐Nanodisks Overcomes Multidrug Resistance. Chem Eur J 2020;26:2470-7. [DOI: 10.1002/chem.201905097] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 Sosnik A. Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing "Generally Recognized As Safe" (GRAS) nanopharmaceuticals: A review. Adv Drug Deliv Rev 2013;65:1828-51. [PMID: 24055628 DOI: 10.1016/j.addr.2013.09.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 8.1] [Reference Citation Analysis]
14 Rochani AK, Ravindran Girija A, Borah A, Maekawa T, Sakthi Kumar D. Heat-Shock Protein 90–Targeted Nano Anticancer Therapy. Journal of Pharmaceutical Sciences 2016;105:1454-66. [DOI: 10.1016/j.xphs.2015.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Sharif Makhmal Zadeh B, Esfahani G, Salimi A. Permeability of Ciprofloxacin-Loaded Polymeric Micelles Including Ginsenoside as P-glycoprotein Inhibitor through a Caco-2 Cells Monolayer as an Intestinal Absorption Model. Molecules 2018;23:E1904. [PMID: 30065147 DOI: 10.3390/molecules23081904] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
16 Zhang X, Chen W, Bai J, Jin L, Kang X, Zhang H, Wang Z. Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells. Aging (Albany NY) 2020;12:8289-300. [PMID: 32396524 DOI: 10.18632/aging.103138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Sobczyński J, Chudzik-rząd B. Mixed micelles as drug delivery nanocarriers. Design and Development of New Nanocarriers. Elsevier; 2018. pp. 331-64. [DOI: 10.1016/b978-0-12-813627-0.00009-0] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Gu W, Chen J, Patra P, Yang X, Gu Q, Wei L, Acker JP, Kong B. Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect. J Biomater Appl 2017;32:66-73. [DOI: 10.1177/0885328217708458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Moesgaard L, Reinholdt P, Nielsen CU, Kongsted J. Mechanism behind Polysorbates' Inhibitory Effect on P-Glycoprotein. Mol Pharm 2022. [PMID: 35512380 DOI: 10.1021/acs.molpharmaceut.2c00074] [Reference Citation Analysis]
20 Feitosa VA, Almeida VCD, Malheiros B, Castro RDD, Barbosa LRS, Cerize NNP, Rangel-yagui CDO. Polymeric micelles of pluronic F127 reduce hemolytic potential of amphiphilic drugs. Colloids and Surfaces B: Biointerfaces 2019;180:177-85. [DOI: 10.1016/j.colsurfb.2019.04.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
21 Thakur PS, Khan AM, Talegaonkar S, Ahmad FJ, Iqbal Z. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer. J Cancer Res Clin Oncol 2016;142:2073-106. [PMID: 27116692 DOI: 10.1007/s00432-016-2167-7] [Reference Citation Analysis]
22 Qin L, Wu L, Jiang S, Yang D, He H, Zhang F, Zhang P. Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin. Journal of Drug Targeting 2018;26:289-95. [DOI: 10.1080/1061186x.2017.1379525] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
23 Ghosh B, Biswas S. Polymeric micelles in cancer therapy: State of the art. J Control Release 2021;332:127-47. [PMID: 33609621 DOI: 10.1016/j.jconrel.2021.02.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
24 Nasr M, Hashem F, Abdelmoniem R, Tantawy N, Teiama M. In Vitro Cytotoxicity and Cellular Uptake of Tamoxifen Citrate-Loaded Polymeric Micelles. AAPS PharmSciTech 2020;21:306. [PMID: 33151433 DOI: 10.1208/s12249-020-01850-6] [Reference Citation Analysis]
25 Ganguly R, Kumar S, Tripathi A, Basu M, Verma G, Sarma H, Chaudhari D, Aswal V, Melo J. Structural and therapeutic properties of Pluronic® P123/F127 micellar systems and their modulation by salt and essential oil. Journal of Molecular Liquids 2020;310:113231. [DOI: 10.1016/j.molliq.2020.113231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
26 Kaur V, Garg T, Rath G, Goyal AK. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target 2014;22:859-70. [PMID: 25101945 DOI: 10.3109/1061186X.2014.947295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]
27 Rathod S, Desai H, Patil R, Sarolia J. Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery-A Concise Outlook. AAPS PharmSciTech 2022;23:55. [PMID: 35043278 DOI: 10.1208/s12249-022-02211-1] [Reference Citation Analysis]
28 Husain A, Makadia V, Valicherla GR, Riyazuddin M, Gayen JR. Approaches to minimize the effects of P-glycoprotein in drug transport: A review. Drug Dev Res 2022. [PMID: 35103340 DOI: 10.1002/ddr.21918] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Al-ali AAA, Sandra L, Versweyveld D, Pijpers I, Dillen L, Vermeulen A, Snoeys J, Holm R, Nielsen CU. High-dose etoposide formulations do not saturate intestinal P-glycoprotein: Development, stability, and pharmacokinetics in Sprague-Dawley rats. International Journal of Pharmaceutics 2020;583:119399. [DOI: 10.1016/j.ijpharm.2020.119399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bhattacharya S, Ghosh A, Maiti S, Ahir M, Debnath GH, Gupta P, Bhattacharjee M, Ghosh S, Chattopadhyay S, Mukherjee P, Adhikary A. Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer. Journal of Controlled Release 2020;322:357-74. [DOI: 10.1016/j.jconrel.2020.03.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
31 Đorđević S, Gonzalez MM, Conejos-Sánchez I, Carreira B, Pozzi S, Acúrcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res 2021. [PMID: 34302274 DOI: 10.1007/s13346-021-01024-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Chen Y, Zhang W, Huang Y, Gao F, Fang X. In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) Peptide. PLoS One 2016;11:e0149952. [PMID: 26930626 DOI: 10.1371/journal.pone.0149952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Liu JS, Wang JH, Zhou J, Tang XH, Xu L, Shen T, Wu XY, Hong Z. Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier. Int J Nanomedicine 2014;9:3923-35. [PMID: 25152622 DOI: 10.2147/IJN.S62263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
34 Helmy SA, El-Bedaiwy HM, El-Masry SM. Applying Biopharmaceutical Classification System criteria to predict the potential effect of Cremophor® RH 40 on fexofenadine bioavailability at higher doses. Ther Deliv 2020;11:447-64. [PMID: 32715985 DOI: 10.4155/tde-2020-0042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kalel R, Mora AK, Patro BS, Palit DK, Nath S. Synergistic enhancement in the drug sequestration power and reduction in the cytotoxicity of surfactants. Phys Chem Chem Phys 2017;19:25446-55. [DOI: 10.1039/c7cp05042a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
36 Zhang M, Liu E, Cui Y, Huang Y. Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer. Cancer Biol Med 2017;14:212-27. [PMID: 28884039 DOI: 10.20892/j.issn.2095-3941.2017.0054] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 12.2] [Reference Citation Analysis]
37 Shamsi S, Chen Y, Lim LY. Characterization and biological properties of NanoCUR formulation and its effect on major human cytochrome P450 enzymes. International Journal of Pharmaceutics 2015;495:194-203. [DOI: 10.1016/j.ijpharm.2015.08.066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
38 Li W, Li X, Gao Y, Zhou Y, Ma S, Zhao Y, Li J, Liu Y, Wang X, Yin D. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity. Mol Pharm 2014;11:71-80. [PMID: 24256068 DOI: 10.1021/mp4004223] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
39 Zhao LY, Zhang WM. Recent progress in drug delivery of pluronic P123: pharmaceutical perspectives. J Drug Target 2017;25:471-84. [PMID: 28135859 DOI: 10.1080/1061186X.2017.1289538] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 4.2] [Reference Citation Analysis]
40 Zeng W, Kwan Law BY, Wai Wong VK, Bik Chan DS, Fai Mok SW, Ying Gao JJ, Yan Ho RK, Liang X, Li JH, Lee MT, Yoon WL, Smolinski MP, Nam Lau JY, Kei Lam CW, Fok M. HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model. Cancer Biol Med 2020;17:986-1001. [PMID: 33299648 DOI: 10.20892/j.issn.2095-3941.2020.0128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Jain S, Reddy VA, Arora S, Patel K. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Drug Deliv and Transl Res 2016;6:498-510. [DOI: 10.1007/s13346-016-0297-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
42 Akhtar N, Talegaonkar S, Ahad A, Khar RK, Jaggi M. Potential of a novel self nanoemulsifying carrier system to overcome P-glycoprotein mediated efflux of etoposide: In vitro and ex vivo investigations. Journal of Drug Delivery Science and Technology 2015;28:18-27. [DOI: 10.1016/j.jddst.2015.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
43 Ma Z, Li N, Zhang B, Hui Y, Zhang Y, Lu P, Pi J, Liu Z. Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality. J Nanobiotechnology 2020;18:123. [PMID: 32887626 DOI: 10.1186/s12951-020-00681-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Yu J, Qiu H, Yin S, Wang H, Li Y. Polymeric Drug Delivery System Based on Pluronics for Cancer Treatment. Molecules 2021;26:3610. [PMID: 34204668 DOI: 10.3390/molecules26123610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Xu W, Ling P, Zhang T. Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013;2013:340315. [PMID: 23936656 DOI: 10.1155/2013/340315] [Cited by in Crossref: 225] [Cited by in F6Publishing: 184] [Article Influence: 25.0] [Reference Citation Analysis]
46 Zhao D, Chen Q, Song H, Luo S, Ge P, Wang Y, Ma J, Li Z, Gao X, Zhao X, Subinuer X, Yang H, Jiang X, Chen Y, Zhu X. Theranostic micelles combined with multiple strategies to effectively overcome multidrug resistance. Nanomedicine (Lond) 2018;13:1517-33. [PMID: 30028224 DOI: 10.2217/nnm-2017-0393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bondar OV, Badeev YV, Shtyrlin YG, Abdullin TI. Lipid-like trifunctional block copolymers of ethylene oxide and propylene oxide: effective and cytocompatible modulators of intracellular drug delivery. Int J Pharm 2014;461:97-104. [PMID: 24239835 DOI: 10.1016/j.ijpharm.2013.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
48 Li G, Shao K, Umeshappa CS. Recent progress in blood-brain barrier transportation research. Brain Targeted Drug Delivery System. Elsevier; 2019. pp. 33-51. [DOI: 10.1016/b978-0-12-814001-7.00003-2] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Giram PS, Wang JT, Walters AA, Rade PP, Akhtar M, Han S, Faruqu FN, Abdel-Bar HM, Garnaik B, Al-Jamal KT. Green synthesis of methoxy-poly(ethylene glycol)-block-poly(l-lactide-co-glycolide) copolymer using zinc proline as a biocompatible initiator for irinotecan delivery to colon cancer in vivo. Biomater Sci 2021;9:795-806. [PMID: 33206082 DOI: 10.1039/d0bm01421d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Akash MS, Rehman K. Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives. J Control Release 2015;209:120-38. [PMID: 25921088 DOI: 10.1016/j.jconrel.2015.04.032] [Cited by in Crossref: 166] [Cited by in F6Publishing: 138] [Article Influence: 23.7] [Reference Citation Analysis]